Latest

Teen Juul
Morning Rounds

Massachusetts files lawsuit against Juul & clinicians tackle climate change

By Shraddha Chakradhar

Infusion drip
First Opinion

From bench to bedside, biologics require excellence at every stage

By Leah Christl

Cell phone_federated learning
First Opinion

Federated learning: collaboration without compromise for health care research

By Marielle S. Gross and Robert C. Miller, Jr.

Radiologists supervise MRI
Opinions Plus

Why medtech is a different beast than biotech in the life sciences pack

By Jonathan P. Gertler

Play
Health

Watch: Why reports about coronavirus death rates can be misleading

By Hyacinth Empinado

Robert Redfield
Exclusive

CDC director: More person-to-person coronavirus infections in U.S. likely, but containment still possible

By Helen Branswell

Insulin diabetes
Pharmalot

Insulin makers object to FDA proposal for speeding arrival of biosimilar insulins

By Ed Silverman

Pharmalot

Pharmalittle: Big pharma isn’t stepping up to make a coronavirus vaccine; Chinese drug maker threatens Gilead patent

By Ed Silverman

The Readout

NIH needs pharma’s help & mental health investment wanes

By Damian Garde

Medical bill
Morning Rounds

Trouble with medical bills & motion capture technology for health

By Shraddha Chakradhar

IV drip in hand
Pharmalot

After a new version of a decades-old drug gets orphan status, the price suddenly skyrockets

By Ed Silverman

gestational carriers
First Opinion

Paying gestational carriers should be legal in all states

By Robert Klitzman

palliative care
First Opinion

A daughter’s plea: Doctors must stop shirking palliative care

By Aimee Gindin

Play
Health

Watch: Hollywood motion capture technology finds a new role in hospital rehab

By Alex Hogan

Cigarette all alone
Politics

New life for an old battle: Trump plan to remove tobacco regulation from FDA draws fire

By Nicholas Florko

Hong Kong port quarantine
Health

Understanding pandemics: What they mean, don’t mean, and what comes next with the coronavirus

By Helen Branswell

Anthony Fauci - Jan 2019
Health

Major drug makers haven’t stepped up to manufacture NIH coronavirus vaccine, top U.S. health official says

By Nicholas Florko

Carbapenem-resistant, Acinetobacter
Pharmalot

WHO adviser says an antimicrobial fund can help a market that ‘needs to be fixed’

By Ed Silverman

Coronavirus illustration
Health

Disease caused by the novel coronavirus officially has a name: Covid-19

By Andrew Joseph

Wuhan hospital bed prep
First Opinion

Hospitals, governments need more data to prepare for the new coronavirus outbreak

By Caitlin M. Rivers and Tom Inglesby

Pharmalot

Pharmalittle: Trump considers executive action to cut drug prices; feds ‘not done’ with generic price-fixing probe

By Ed Silverman

The READOUT
The Readout

Moderna’s burn rate & Exelixis’s second shot

By Damian Garde

HHS headquarters
Morning Rounds

WHO meeting on coronavirus response & new HHS facility for biotechnology

By Shraddha Chakradhar

Hospital bed_religious freedom/tolerance in health care
First Opinion

A strategy for securing religious freedom and tolerance in health care

By Ira Bedzow

Bayer Heroin opioids
First Opinion

What an 1890s opioid epidemic can teach us about ending addiction today

By Haider J. Warraich

Jaime Herrera Beutler
Politics

In reelection bid, a GOP lawmaker campaigns on Pelosi’s drug pricing bill

By Lev Facher

China virus statue
Biotech

U.S. biotechs fear the coronavirus outbreak will delay their China-based research

By Kate Sheridan

Priscilla Chan
Heavyweights

Priscilla Chan charts an ambitious, unglamorous course to fight disease. (Her husband is involved, too.)

By Rebecca Robbins

ProstateCancerCell
Biotech

With new combination drug data, Exelixis takes another shot at prostate cancer treatment

By Adam Feuerstein

Your daily dose of news in health and medicine

Privacy Policy